phenotype

NEUROINFLAMMATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NEUROINFLAMMATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

10810Connections

30Hypotheses

30Analyses

50Outgoing

50Incoming

2Experiments

20Debates

Summary

NEUROINFLAMMATION is a phenotype associated with neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with AD, ALS, ALZHEIMER. Connected to 2614 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Immune Atlas: Neuroinflammation Analysis

analysis · 0 words

→

Pathway Diagram

graph TD
    subgraph Signaling["Signaling"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| NEURODEGENERATION["NEURODEGENERATION"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Als["Als"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Neuroinflammation_1["Neuroinflammation"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Inflammation_2["Inflammation"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Autophagy["Autophagy"]
        CYTOKINES["CYTOKINES"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        MITOCHONDRIAL_DYSFUNCTION["MITOCHONDRIAL DYSFUNCTION"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    end
    subgraph Pathology["Pathology"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| NEURON["NEURON"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| TAU["TAU"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| Neuroinflammation["Neuroinflammation"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| Inflammation["Inflammation"]
        APOE["APOE"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        MICROGLIA["MICROGLIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        APP["APP"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        MITOCHONDRIA["MITOCHONDRIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    end
    style NEUROINFLAMMATION fill:#5d4400,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style NEURODEGENERATION fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style TAU fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Neuroinflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Inflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Neuroinflammation_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Inflammation_2 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MITOCHONDRIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style CYTOKINES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MITOCHONDRIAL_DYSFUNCTION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (4230)

Target	Relation	Type	Str
Toll-Like Receptor	activates	pathway	1.00
Inflammation	interacts_with	disease	1.00
Dementia	associated_with	disease	1.00
Stroke	associated_with	disease	1.00
Neuroinflammation	associated_with	disease	1.00
Inflammation	associated_with	disease	1.00
Inflammation	inhibits	disease	1.00
Neurodegeneration	causes	disease	1.00
Als	associated_with	disease	1.00
Alzheimer	activates	disease	1.00
Infection	activates	disease	1.00
Neurodegeneration	associated_with	disease	1.00
Neurodegeneration	associated_with	disease	1.00
Microrna	regulates	pathway	1.00
STROKE	associated_with	gene	1.00
MICROGLIA	inhibits	gene	1.00
MICROGLIA	therapeutic_target	gene	1.00
MICROGLIA	regulates	gene	1.00
Inflammation	associated_with	disease	1.00
Als	associated_with	disease	1.00
Neuroinflammation	therapeutic_target	disease	1.00
Neuroinflammation	expressed_in	disease	1.00
Epilepsy	activates	disease	1.00
MICROGLIA	activates	gene	1.00
Inflammation	inhibits	disease	1.00
Neuroinflammation	interacts_with	disease	1.00
Als	causes	disease	1.00
Microrna	regulates	pathway	1.00
Neuroinflammation	inhibits	disease	1.00
Blood-Brain Barrier	activates	pathway	1.00
neurodegeneration	causes	phenotype	1.00
Inflammasome	activates	pathway	1.00
Stroke	activates	disease	1.00
Als	regulates	disease	1.00
Neurodegeneration	inhibits	disease	1.00
Aging	activates	disease	1.00
Parkinson	activates	disease	1.00
Alzheimer	activates	disease	1.00
OXIDATIVE STRESS	associated_with	gene	1.00
Parkinson	associated_with	disease	1.00
Autoimmune	activates	disease	1.00
Inflammation	expressed_in	disease	1.00
Alzheimer	therapeutic_target	disease	1.00
Dementia	activates	disease	1.00
Als	inhibits	disease	1.00
Inflammation	therapeutic_target	disease	1.00
neurodegeneration	activates	process	1.00
Parkinson	regulates	disease	1.00
Als	activates	disease	1.00
Autophagy	activates	pathway	1.00

Incoming (6580)

Source	Relation	Type	Str
entities-complement-system	involved_in	wiki	0.00
entities-microglia-in-neurodegeneration	involved_in	wiki	0.00
GENES	activates	gene	1.00
NEURODEGENERATION	regulates	gene	1.00
Multiple Sclerosis	activates	disease	1.00
ALZHEIMER'S DISEASE	regulates	gene	1.00
MITOCHONDRIA	activates	gene	1.00
NEUROINFLAMMATION	associated_with	gene	1.00
AGING	associated_with	gene	1.00
ALZHEIMER'S DISEASE	associated_with	gene	1.00
NEURODEGENERATIVE DISORDERS	associated_with	gene	1.00
ALZHEIMER'S DISEASE	regulates	gene	1.00
MITOCHONDRIAL DYSFUNCTION	therapeutic_target	gene	1.00
MITOCHONDRIAL DYSFUNCTION	therapeutic_target	gene	1.00
ASTROCYTES	associated_with	gene	1.00
ALZHEIMER	associated_with	gene	1.00
ALZHEIMER	associated_with	gene	1.00
NEURODEGENERATIVE DISEASES	associated_with	gene	1.00
AGING	regulates	gene	1.00
MICROGLIA	associated_with	gene	1.00
TAU	associated_with	gene	1.00
MITOCHONDRIA	activates	gene	1.00
Als	associated_with	disease	1.00
INFLAMMATION	associated_with	gene	1.00
NEUROTOXICITY	activates	gene	1.00
AGING	associated_with	gene	1.00
NEURODEGENERATIVE DISORDERS	associated_with	gene	1.00
NEURODEGENERATIVE DISEASES	therapeutic_target	gene	1.00
MICROGLIA ACTIVATION	activates	gene	1.00
MICROGLIA ACTIVATION	activates	gene	1.00
NEUROTOXICITY	activates	gene	1.00
Aging	associated_with	disease	1.00
GENES	regulates	gene	1.00
INFLAMMATION	associated_with	gene	1.00
OXIDATIVE STRESS	inhibits	gene	1.00
NEURODEGENERATION	therapeutic_target	gene	1.00
ASTROCYTES	therapeutic_target	gene	1.00
NEURODEGENERATION	therapeutic_target	gene	1.00
TAU	therapeutic_target	gene	1.00
CYTOKINES	inhibits	gene	1.00
AGING	regulates	gene	1.00
ASTROCYTES	activates	gene	1.00
INFLAMMATION	inhibits	gene	1.00
ASTROCYTES	activates	gene	1.00
ASTROCYTES	regulates	gene	1.00
NEUROINFLAMMATION	interacts_with	gene	1.00
INFLAMMATION	therapeutic_target	gene	1.00
NEUROINFLAMMATION	inhibits	gene	1.00
MICROGLIA	inhibits	gene	1.00
TNF-Α	activates	gene	1.00

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43	0.824	neurodegeneration	What are the mechanisms by which gut mic
Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone	0.808	neurodegeneration	What are the precise temporal dynamics o
SIRT1/PGC-1α Axis Activation to Preserve Mitochondrial Resil	0.778	neurodegeneration	Gut Microbiome Analysis in Parkinson's D
Microglia-Mediated Neuroinflammation as a Disease-Amplifying	0.720	neurodegeneration	Cross-disease neurodegeneration mechanis
Microglial Disease-Associated States: TREM2-Independent Path	0.710	neurodegeneration	Cell type vulnerability debate in Alzhei

TLR4/MyD88/NF-κB Axis Blockade to Interrupt LPS-Mediated Gut	0.703	neurodegeneration	How do gut microbiome-derived metabolite
AQP4 Dysregulation Promotes Neuroinflammation Through Impair	0.680	neurodegeneration	What are the specific molecular mechanis
GFAP-Bearing Circulating Extracellular Vesicles Originating	0.665	-	What blood-brain barrier permeability ch
NeuroD1-Mediated Astrocyte Reprogramming Attenuates Neuroinf	0.650	neurodegeneration	epigenetic reprogramming aging neurons
STING Antagonism Prevents Acute-to-Chronic Neuroinflammation	0.601	neuroinflammation	What molecular mechanisms drive the tran
Cardiovascular-Neuroinflammation Crosstalk Interruption	0.587	alzheimers	Neuroinflammation and microglial priming
Astrocyte cGAS/STING Activation Converts Protective into Des	0.580	neuroinflammation	How does chronic cGAS/STING activation d
Neuroinflammation-Driven TDP-43 Mislocalization via Microgli	0.580	neurodegeneration	How does APOE4 mechanistically increase
Astrocyte-targeted LNP-APOE4 silencing to restore lipid home	0.573	neurodegeneration	-
PINK1/PARK2-Mediated Mitophagy Enhancement for Neuroinflamma	0.571	neuroinflammation	Immune atlas neuroinflammation analysis
BET Bromodomain Inhibition for Neuroinflammation Suppression	0.550	neurodegeneration	Comparative epigenetic signatures across
Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammatio	0.532	translational-neuroscience	Which metabolic biomarkers can distingui
Gamma/tFUS Entrainment as Biomarker Modulator of Neuroinflam	0.520	alzheimers	Closed-loop transcranial focused ultraso
Astrocyte senescence and SASP-driven neuroinflammation in AL	0.510	neurodegeneration	Test
Astrocyte-Specific DGAT1 Inhibition to Prevent Lipid Droplet	0.510	lipidomics	Lipid metabolism dysregulation in Alzhei
LDLR-Targeted Anti-Inflammatory Antibody Delivery for Neuroi	0.498	neuropharmacology	What is the actual quantitative contribu
Testosterone-Derived DHT Amplifies Microglial Androgen Recep	0.490	neuroinflammation	How do regional, age, and sex-dependent
Necroptosis-cGAS Feedforward Loop Converts TDP-43 Pathology	0.460	neuroinflammation	How does chronic cGAS/STING activation d
ACSL4-Mediated Neuroinflammatory Amplification in Disease-As	0.459	alzheimers	Cell type vulnerability in Alzheimers Di
SPI1-Mediated Metabolic Reprogramming in Neuroinflammation	0.455	neuroinflammation	How does SPI1 transcriptionally regulate
SPI1-C1Q Transcriptional Circuit Drives Cerebrovascular Neur	0.455	neuroinflammation	How does SPI1 transcriptionally regulate
Mitophagy Enhancement Blocks STING-Mediated Neuroinflammatio	0.380	neuroinflammation	Immune atlas neuroinflammation analysis
ω-3 Docosahexaenoic Acid (DHA) Metabolism via 15-Lipoxygenas	0.380	lipidomics	Lipid metabolism dysregulation in Alzhei
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neuroinfla	0.380	neurodegeneration	Spatial Transcriptomics Analysis of Alzh
LDLR-Mediated Neuroinflammation Modulation Strategy	0.380	neuropharmacology	What is the actual quantitative contribu

Mentioning Analyses (30)

Scientific analyses that reference this entity

Cross-disease neurodegeneration mechanism synthesis

neurodegeneration | 2026-04-28 | 17 hypotheses Top: 0.828

Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to

Alzheimer's disease | 2026-04-28 | 7 hypotheses Top: 0.670

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

neurodegeneration | 2026-04-28 | 7 hypotheses Top: 0.662

Test Preregistration Analysis

neurodegeneration | 2026-04-27 | 7 hypotheses Top: 0.710

How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegen

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.728

Experiments (2)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
PGC-1α knockout analysis of PV+ interneuron maturation	validation	neurodevelopmental disorders	0.850	0.00	knockout mice	proposed	N/A
PV+ interneuron subtype diversification analysis	exploratory	neurodevelopmental disorders	0.750	0.00	mouse cortical PV+ interneuron	proposed	N/A

Related Papers (10)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861]	["Han X", "Sun S", "Sun Y", "Song Q", "Z	Autophagy	2020	1
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025	0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025	0
Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438]	Hegdekar N, Sarkar C, Bustos S, Ritzel R	Autophagy	2023	0
Inflammasome assembly in neurodegenerative diseases. [PMID:37633753]	Singh J, Habean ML, Panicker N	Trends in neurosciences	2023	0
NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pat [PMID:34877938]	Li S, Sun Y, Song M, Song Y, Fang Y, Zha	JCI insight	2021	0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554]	Marogianni C, Sokratous M, Dardiotis E,	International journal of molec	2020	0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554]	Marogianni C, Sokratous M, Dardiotis E,	International journal of molec	2020	0
Multiple Sclerosis Pathology. [PMID:29358320]	Lassmann H	Cold Spring Harbor perspective	2018	0
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodeg [PMID:30381407]	Gordon R, Albornoz EA, Christie DC, Lang	Science translational medicine	2018	0

Debates (20)

Multi-agent debates referencing this entity

Second debate: Microglial TREM2-SYK Pathway Enhancement

closed · Rounds: 4 · Score: 0.57 · 2026-04-28

Structured research brief for hypothesis h-var-b7e4505525: Closed-loop transcran

closed · Rounds: 4 · Score: 0.63 · 2026-04-28

Which AD, PD, ALS, and FTD mechanisms recur across disease boundaries and yield

closed · Rounds: 4 · Score: 0.72 · 2026-04-28

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

closed · Rounds: 4 · Score: 0.76 · 2026-04-28

Test question for preregistration

closed · Rounds: 4 · Score: 0.77 · 2026-04-28

Extended debate: CYP46A1 Overexpression Gene Therapy

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: Chromatin Remodeling-Mediated Nutrient Sensing Restoration

closed · Rounds: 4 · Score: 0.46 · 2026-04-27

Debate: LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Primin

closed · Rounds: 4 · Score: 0.12 · 2026-04-27

Debate: ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE P

closed · Rounds: 4 · Score: 0.42 · 2026-04-27

Related Research

Hypotheses and analyses mentioning NEUROINFLAMMATION in their description or question text

NEUROINFLAMMATION

Understanding Entity Pages

Summary

Wiki Pages (1)

Immune Atlas: Neuroinflammation Analysis

Pathway Diagram

Outgoing (4230)

Incoming (6580)

Targeting Hypotheses (30)

Mentioning Analyses (30)

Cross-disease neurodegeneration mechanism synthesis

Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

Test Preregistration Analysis

How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegen

How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegen

What are the mechanisms by which microglial senescence contributes to ALS pathol

Gut-Brain Axis in Parkinson's Disease: Molecular Mechanisms, Neuroinflammation,

Microglial senescence in Alzheimer and Parkinson disease progression

What are the optimal oxygen pressure, duration, and frequency parameters for HBO

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

Does C1q function differ based on subcellular localization or binding partner id

Comparative epigenetic signatures: DNA methylation age acceleration and histone

Comparative epigenetic signatures: DNA methylation age acceleration and histone